Dudediligence.

Kiora Pharmaceuticals, Inc

KPRXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Mar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25
Net income, by quarter
−$3.4MSep ’24−$4.2MDec ’24−$2.2MMar ’25−$2.2MJun ’25$26,806Sep ’25$4.3MDec ’25−$2.4MMar ’26−$2.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$0.00none on file$0.00$16.0M$0.00
Operating income−$14.2M−$12.3M−$12.6M$4.5M−$12.8M
Net income−$13.8M−$13.6M−$12.5M$3.6M−$10,835
Operating cash flow−$10.7M−$10.4M−$9.6M$8.6M−$10.0M
Free cash flow−$10.7M−$10.4M−$9.6M$8.6M−$10.1M
Cash$7.9M$6.0M$2.5M$3.8M$8.7M
Shares outstanding316.6K1.8M856.2K3.0M3.8M